Bradley A. Hooker

Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats

Gin C. Hsieh, Madhavi Pai, Prasant Chandran et al. · British Journal of Pharmacology · 2010 · 136 citations · Full text

Medicine, Neuroscience, Pharmacology +17

<i>In vitro</i>pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB₂receptor?

B. B. Yao, Sromona Mukherjee, Yaotian Fan et al. · British Journal of Pharmacology · 2006 · 113 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +15

Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3 H-thiazol-(2 Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

Betty Yao, Gin C. Hsieh, A.V. Daza et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 91 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates

Peer B. Jacobson, Robin J Goody, Matthew S. Lawrence et al. · Neurobiology of Disease · 2021 · 42 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Pharmacological modulation of brain activity in a preclinical model of osteoarthritis

Jaymin Upadhyay, Scott Baker, Rajasimhan Rajagovindan et al. · NeuroImage · 2012 · 26 citations

Medicine, Neuroscience, Pharmacology +7